ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
Main Authors: | Fábio Vieira TEIXEIRA, Paulo Gustavo KOTZE, Adérson Omar Mourão Cintra DAMIÃO |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
|
Series: | Arquivos de Gastroenterologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000200060&lng=en&tlng=en |
Similar Items
-
BIOSIMILARS IN INFLAMMATORY BOWEL DISEASES: an important moment for Brazilian gastroenterologists
by: Fábio Vieira TEIXEIRA, et al.
Published: (2015-03-01) -
RESEARCH IN INFLAMMATORY BOWEL DISEASES IN LATIN AMERICA: a challenge ahead
by: Paulo Gustavo KOTZE
Published: (2014-12-01) -
BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES
by: Abel Botelho QUARESMA, et al. -
VITAMIN D DEFICIENCY AMONG INFLAMMATORYBOWEL DISEASE PATIENTS IN ARGENTINA: A CROSS-SECTIONAL STUDY
by: María Constanza TORELLA, et al. -
Evolução da ocorrência (1980-1999) da doença de Crohn e da retocolite ulcerativa idiopática e análise das suas características clínicas em um hospital universitário do sudeste do Brasil Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil
by: Marcellus Henrique L. P. SOUZA, et al.
Published: (2002-04-01)